Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial

Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial

Abstract Background Cardiovascular (CV) polypills are a useful baseline treatment to prevent CV diseases by combining different drug classes in a single pill to simultaneously target more than one risk factor. The aim of the present trial was to determine whether the treatment with the CNIC-polypill...

Full description

Bibliographic Details
Main Authors: José M. Mostaza, Carmen Suárez-Fernández, Juan Cosín-Sales, Ricardo Gómez-Huelgas, Carlos Brotons, Francisco Pestana Araujo, Gabriela Borrayo, Emilio Ruiz, VULCANO investigators
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Cardiovascular Disorders
Subjects:
Cardiovascular disease
Primary prevention
Fixed-dose combination
Polypill
Non-inferiority trial
Cardiovascular risk factors
Online Access:https://doi.org/10.1186/s12872-022-03013-w

Internet

https://doi.org/10.1186/s12872-022-03013-w

Similar Items